University of Rochester Medical Center
SearchDirectoryNewsEventsStrong HealthURMC Home
Community & Preventive Medicine Department lecture

EducationResearchDepartmentHome

FACULTY DIRECTORY

M.D., 1997, Johns Hopkins University School of Medicine, Baltimore, MD

MPH, 2003, University of Rochester

A.B., 1993, Washington University, St. Louis, MO History/ Biology

M. Jacob Adams, MD, MPH

Assistant Professor

Division of Epidemiology, Community & Preventive Medicine

Wilmot Cancer Fellow


Contact Information:

University of Rochester
Community & Preventive Medicine
601 Elmwood Avenue, Box 644
Rochester, NY 14642

Office: 4-W126
Phone: (585) 275-5951
Fax: (585) 461-4532

Email: jacob_adams@urmc.rochester.edu

Research:

Pediatric, cardiovascular and cancer epidemiology

Courses:

PM 414: History of Epidemiology

PM 417: Molecular Epidemiology

PM 418: Cardiovascular Epidemiology and Prevention

OVERVIEW
I am interested in the long-term health impact of the treatment of childhood cancer therapy. I am particularly interested in dyslipidemia and other cardiovascular risks in childhood cancer survivors. My primary research project explores the long-term cardiovascular and oncologic consequences of radiation therapy to the chest. More broadly, I am interested in pediatric, cardiovascular and cancer epidemiology
RECENT PUBLICATIONS
Articles
  • Adams MJ, Prosnitz RG, Constine LS, M.D, Marks LB, Lipshultz SE. Screening for CVD in Survivors of Thoracic Radiation. Seminars in Radiation Oncology. (In Press 2006).
  • Adams MJ, Hinkle AS, Constine LS, Lipshultz SE. Anthracycline Cardiotoxicity in a Childhood Cancer Survivor: A Case Report and Review.  American Journal of Oncology Review. January 2006; 5(1):31-38.
  • Adams MJ, Duffy SA, Constine LS, Lipshultz SE. Cardiovascular Effects of Cancer Therapy. Schwartz C, Hobbie W, Constine L, Ruccione K. eds.Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach, 2nd edition. New York: Springer-Verlag GmbH & Co.KG; 2005; 121-147.
  • Adams MJ, Lipshultz SE. The Pathophysiology of Anthracycline- and Radiation-Associated Cardiomyopathies: Implications for Screening and Prevention. Pediatric Blood and Cancer June 15, 2005; 44(7): 600-606.
  • Tisma-Dupanovic S, Harmon WG, Adams MJ, Dadlani GH, Kozlowski A, Duffy S, Harbowy L, Zareba K, French C, McLaughlin K, Lipshultz SE. Cancer Therapy-Related Cardiotoxicities. In Pediatric Heart Failure (ed. Shaddy RE, Wernovsky G) Boca Raton: Taylor & Francis. Pages 665-738 (2005).
  • Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, Greenbaum N, Mauch, P, Lipshultz SE. Cardiovascular Status in Long-term Survivors of Hodgkin’s Disease Treated with Chest Radiotherapy. J Clin Oncol: Aug 2004;22(15): 3139-3148.
  • Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, Greenbaum N, Mauch, P, Lipshultz SE. Cardiovascular Status in Long-term Survivors of Hodgkin’s Disease Treated with Chest Radiotherapy. J Clin Oncol: Aug 2004;22(15): 3139-3148.
  • Adams MJ, Lipshultz SE, Schwartz C, Fajardo L, Coen V, Constine LS. Cardiac Effects of Radiotherapy: Current Management and Investigations. Seminars in Radiation Oncology July 2003; 13(3): 346-356.
  • Adams MJ, Hardenbergh P, Constine LS, Lipshultz SE. Radiation-Associated Cardiovascular Disease. Critical Reviews in Oncology/Hematology 2003; 45(1): 55-75.
  • Adams MJ, Constine LS, Lipshultz SE. Radiation (Heart Disease). In: Crawford MH, DiMarco JP eds. Cardiology 2nd edition London: Harcourt Brace; 2003.
  • Simbre VC. II, Adams MJ, Deshpande SS, Duffy SA, Miller TL, Lipshultz SE. Cardiomyopathy Caused by Antineoplastic Drugs. Current Treatment Options in Cardiovascular Medicine. Dec 2001;3(6): 493-506.
  • Adams MJ, Constine LS, Lipshultz SE. Radiation Heart Disease. In: Crawford MH, DiMarco JP eds. Cardiology London: Mosby; 2001.
  • Chiang V, Burns JP, Rifai N, Lipshultz SE, Adams MJ, Weiner DL. Cardiac Toxicity of Intravenous Terbutaline for the Treatment of Severe Asthma in Children: A Prospective Assessment. Journal of Pediatrics: July 2000;137(1):73-77.
Abstracts
  • Adams JM (sic), Lipsitz SR, Colan SD, Mauch PM, Diller L, Treves ST, Tarbell NJ, Greenbaum N, Lipshultz SE. Sponsor Fisher, R. Late Cardiotoxicity of Mediastinal Irradiation. Featured Oral Presentation at the Annual Meeting of American Society of Clinical Oncology Chicago, IL. June 1, 2003.
  • Hinkle A, Proukou C, French C, Adams MJ, Miller T, Constine LS, Lipshultz SE. Development of A Cardiac Risk Factor Profile in Survivors of Pediatric Malignancy. Poster-Session, 6th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer. June 23-24, 2000, Niagara-on-the-Lake, Ontario, Canada.
  • Adams MJ, Constine LS, Lipshultz SE. Radiation-Induced Heart Disease. Poster-Session, University of Rochester Cancer Center Fourth Annual Research Symposium. September 14, 1999, Rochester, New York.
  • Adams MJ, Fisher SG. From Cowpox to SARS: A History of Epidemiology Class for a PhD Program in Epidemiology. Annual Meeting American College of Epidemiology. Boston, MA. September 2004.
  • Adams MJ, Dozier A, Fisher SG.  Resurrecting a cohort to evaluate the life-long effects of mediastinal irradiation.  Annual Meeting American Society of Preventive Oncology Bethesda, MD. March 15, 2004.
  • Hale ER, Constine LS, Adams MJ, French CA, Lipsitz SR, Hinkle AS, Kozlowski AM, Proukou C, Miller TL, Lipshultz SE. Cardiac Radiation Dose in Pediatric Cancer Patients is Associated with Tricuspid Regurgitation and Decreased Left Ventricular Wall Thickness. Annual Meeting of the American Society of Therapeutic Radiation Oncologists, October 2004.
  • Adams MJ, Fisher SG. From Cowpox to SARS: A History of Epidemiology Class for a PhD Program in Epidemiology. Annual Meeting American College of Epidemiology. Boston, MA. September 13, 2004.
  • Lipshultz SE, Lipsitz SR, Hinkle AS, Constine LS, French CA, Rovitelli AMK, Proukou C, Lopez-Mitnik G, Adams MJ, Hale R, Rifai N, Miller TL. Cardiovascular Status, Subsequent Risk, and Associated Factors in Long-term Survivors of Childhood Cancer in a Population-Based NCI Study.  American Heart Association Scientific Sessions. November 14, 2005 (Best Poster in category).
  • Adams MJ, Ng AK, Mauch PM, Lipshultz SE.  Cardiac Status Predicts Quality of Life in Hodgkin’s Disease Survivors Treated with Mediastinal Radiotherapy. 42nd Annual Meeting of American Society of Clinical Oncology Atlanta, GA, June 4, 2006.
  • Adams MJ, Ng AK, Mauch PM, Lipshultz SE.  Cardiac Status Predicts Quality of Life in Hodgkin’s Disease Survivors. 9th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer.  Niagara-on-the-Lake, Ontario, Canada. June 9-10, 2006.
  • Adams MJ, Dozier A, Shore R, PhD, Stovall M, Dye T, Duckett J; Fisher S, PhD, Pearson TA  Reestablishing a Dormant Cohort to Evaluate the Long-term Cardiovascular Effects of Low Dose Chest Irradiation.  American Statistical Association Meeting on Radiation and Health. Monterey, CA, June 20, 2006.